Trade NeoGenomics - NEOus CFD
Add to favourite- Summary
- Historical Data
Spread | 0.08 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 13.83 |
Open | 13.67 |
1-Year Change | -4.34% |
Day's Range | 13.67 - 14.28 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Apr 26, 2024 | 14.11 | 0.28 | 2.02% | 13.83 | 14.31 | 13.54 |
Apr 25, 2024 | 13.83 | 0.20 | 1.47% | 13.63 | 13.95 | 13.49 |
Apr 24, 2024 | 13.98 | -0.01 | -0.07% | 13.99 | 14.18 | 13.77 |
Apr 23, 2024 | 14.12 | 0.82 | 6.17% | 13.30 | 14.40 | 13.25 |
Apr 22, 2024 | 13.39 | -0.13 | -0.96% | 13.52 | 13.62 | 13.30 |
Apr 19, 2024 | 13.49 | -0.17 | -1.24% | 13.66 | 13.74 | 13.39 |
Apr 18, 2024 | 13.74 | 0.09 | 0.66% | 13.65 | 14.05 | 13.54 |
Apr 17, 2024 | 13.64 | -0.19 | -1.37% | 13.83 | 13.83 | 13.58 |
Apr 16, 2024 | 13.81 | 0.27 | 1.99% | 13.54 | 13.88 | 13.38 |
Apr 15, 2024 | 13.70 | -0.39 | -2.77% | 14.09 | 14.18 | 13.50 |
Apr 12, 2024 | 14.05 | -0.17 | -1.20% | 14.22 | 14.41 | 13.84 |
Apr 11, 2024 | 14.47 | 0.04 | 0.28% | 14.43 | 14.56 | 14.21 |
Apr 10, 2024 | 14.41 | -0.06 | -0.41% | 14.47 | 14.84 | 14.33 |
Apr 9, 2024 | 15.19 | 0.44 | 2.98% | 14.75 | 15.52 | 14.75 |
Apr 8, 2024 | 14.81 | -0.08 | -0.54% | 14.89 | 15.13 | 14.58 |
Apr 5, 2024 | 14.89 | 0.39 | 2.69% | 14.50 | 14.97 | 14.47 |
Apr 4, 2024 | 14.76 | -0.01 | -0.07% | 14.77 | 15.40 | 14.74 |
Apr 3, 2024 | 14.83 | 0.26 | 1.78% | 14.57 | 15.09 | 14.50 |
Apr 2, 2024 | 14.75 | -0.22 | -1.47% | 14.97 | 14.97 | 14.50 |
Apr 1, 2024 | 15.35 | -0.22 | -1.41% | 15.57 | 15.57 | 14.87 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
NeoGenomics Company profile
About NeoGenomics, Inc.
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories. The Company operates through two segments: the Clinical Services Segment and the Pharma Services Segment. The Clinical Services segment provides various clinical testing services to community-based pathology practices, oncology practices, hospital pathology labs, reference labs, and academic centers with reimbursement from various payers, including client direct billing, commercial insurance, Medicare and other government payers, and patients. The Pharma Services segment supports pharmaceutical firms in their drug development programs by providing testing services and data analytics for clinical trials and research. It offers testing services, which include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, immunohistochemistry (IHC) and digital imaging, molecular testing and morphologic analysis. It operates testing laboratories in United States, Europe and Asia.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, NeoGenomics, Inc. revenues increased 9% to $484.3M. Net loss totaled $8.3M vs. income of $4.2M. Revenues reflect Clinical Services segment increase of 6% to $404.2M, Pharma Services segment increase of 29% to $80.2M. Net loss reflects General and administrative increase of 38% to $167.2M (expense), Sales and marketing increase of 31% to $62.6M (expense).
Equity composition
Common Stock $0.001 Par, 03/12, 100M auth., 43,236,498. issd. Insiders own approx. 46.49%.
Industry: | Medical & Diagnostic Laboratories |
9490 Neogenomics Way
FORT MYERS
FLORIDA 33912
US
News
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com